Aging and the musculoskeletal system

Annals of the Rheumatic Diseases

Volumn 56, Issue 10, 1997, Pages 578-585

  Hamerman, David ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; DENSITOMETRY; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; GENETIC ANALYSIS; GERIATRICS; HUMAN; MUSCULOSKELETAL SYSTEM; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RHEUMATOLOGY; RISK FACTOR;

EID: 0030796673     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.56.10.578     Document Type: Review

References (97)

1. Rosenthal M L, ed. Selected poems and two plays of William Butler Yeats. New York: MacMillan Publishing, 1962: 30.
2. Hamerman D, Clinical implications of osteoarthritis and ageing. Ann Rheum Dis 1995;54:82 5.
3. Praemer A, Furner S, Rice D P. Mnseuloskeletal conditions in the United States. Park Ridge, IL: American Academy of Orthopaedic Surgeons, 1992.
4. Yelin E, Callahan L F. The economic cost and social and psychological impact of musculoskeletal conditions. Arthritis Rheum 1995;38:1351 62.
5. Melton L J, III. How many women have osteoporosis now? J Hone Miner Res 1996;11:1205 8.
6. Fox N R, Chan J K, Thames M, Melton I, J, III. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1095: report from the National Osteoporotic Foundation. J Hone Miner Res 1997;12:24 35.
7. Fried L P, Guralnik J M. Disability in older adults: evidence regarding significance, etiology, and risk. I Am Geriatr Soc 1997;45:92 100.
8. Jette A M. Musculoskeletal impairments and associated physical disability in the elderly: insights from epidemiological research. In: Buckwalter J A, Goldberg V M, Woo S L-Y, eds. Musuloskeletal soft-tissue aging: impact on mobility, Rosemont IL: American Academy of Orthopaedic Surgery, 1993: 7 22.
9. Cawston T F, Riley G P, Hazleman B L. Tendon lesions and soft tissue rheumatism - great outback or great opportunity? Ann Rheum Dis 1996;55:1 3.
10. Verbrugge L M, Patrick D L. Seven chronic conditions: their impact on US adults' activity levels and use of medical services. Am J Public Health 1995;85:173 82.
11. Yarasheski K E. Effect of exercise on muscle mass in the elderly. In: Perry H M, III, Morley J E, Coe R M, eds. Aging and musculoskeletal disorders. New York: Springer Publishing, 1993: 199-213.
12. Buchner D M, Cress M E, Wagner E H, de Lateur B J, Price R, Abrass I B. The Seattle FICSIT/Movelt study: the effect of exercise on gait and balance in older adults. J Am Geriatr Soc 1993;41:321 5.
13. Fried L P, Williamson J D, Kasper J. The epidemiology of frailty: scope of the problem. In: Perry II M, III, Morley J E, Coe R M, eds. Aging and musculoskeletal disorders. New York: Springer Publishing, 1993: 3-15.
14. Pope D P, Croft P R, Pritchard C M, Silman A J. Prevention of shoulder pain in the community: the influence of case definition. Ann Rheum Dis 1997;56:308 12.
15. Chard M D, Hazleman R, Hazleman B L, King R H, Reiss B B. Shoulder disorders in the elderly: a community survey. Arthritis Rheum 1991;34:766-9.
16. Evans W J. What is sarcopema? J Gerontol 1995;50A:5-8.
17. Nair K S. Aluscle protein turnover: methodological issues and the effect of aging. J Gerontol 1995;50A:107-12.
18. Larsson L. Alotor units: remodeling in aged animals. J Gerontol 1095;50A:91-5.
19. Bassey E J. Exercise in primary prevention of osteoporosis in women. Ann Rheum Dis 1995;54:861-2.
20. Guccione A A, Felson D T, Anderson J J, Anthony J A, Zhang Y, Wilson P W F, et al. Specific diseases and their effects on the functional limitations of elderly in the Framingham study. Am J Public Health 1994;84:351-8.
21. Fiatarone M A, Marks E C, Ryan N D, Meredith C N, Upsitz L A, Elvans W J. High-intensity strength training in nonagenarians: effects on skeletal muscle. JAMA 1990; 263:3029-34.
22. Bloomfield SA. Changes in musculoskeletal structure and function with prolonged bed rest. Med Sci Sports Exerc 1997;29:197-206.
23. Greenleaf J E. Intensive exercise training during bed rest attenuates deconditioning. Med Sci Sports Exerc 1097; 20:207-15.
24. Ettinger W H, Burns R, Messier S P, Applegate W, Rejeski W J, Morgan T, et al. A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis. JAMA 1997;277:25-31.
25. Slemenda C, Brandt K D, Heilman D K, Mazzuca S, Braunstein F M, Katz B P, et al. Quadriceps weakness and osteoarthritis of the knee. Ann Intern Med 1907;128:97 104.
26. Hochberg M C. Epidemiologic considerations in the primary prevention of osteoarthritis. J Rheumatol 1991; 18:1438-40.
27. Hamerman D. The aging skeleton - osteoarthritis and osteoporosis. In: Hamerman D, ed. Osteoarthritis. Public health implications for au aging population. Baltimore: Johns Hopkins University Press, 1997: 99-121.
28. Calvo M S, Eyre D R, Gundberg C M. Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev 1996;17:333-68.
29. Kraus V B. Pathogenesis and treatment of osteoarthritis. Med Clin North Am 1997;81:85-112.
30. Lohmander L S, Felson D T. Defining the role of molecular markers to monitor disease, intervention, and cartilage breakdown in nsteoarthritis. J Rheumatol 1997;24:782-5.
31. McAlindon T E, Felson D T, Zhang Y, Hannan M T, Aliabadi P, Weissman B, et al. Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham study. Ann Intern Med 1996;125:353-9.
32. Fujita T. Vitamin D in the treatment of osteoporosis revisited. Proc Soc Exp Biol Med 1996;212:110-5.
33. Vandevyer C, Wylin T, Cassiman J J, Rous J, Oeusers P. Influence of the vitamin D receptor gene alleles on bone mineral density in postmenopausal and osteoporotic women. J Bone "Miner Res 1997;12:241-7.
34. Cooper G S, Umbach D M. Are vitamin D receptor polymorphisms associated with hone mineral density? A meta-analysis. J Bone Miner Res 1996;11:1841-4.
35. Cooper C, Fall C, Egger P, Hobbs R, Kastell R, Barker D. Growth in infancy and bone mass in later life. Ann Rheum Dis 1997;56:17-21.
36. Spector T D, Cicuttini F, Baker J, Loughlin J, Hart D. Genetic influences on osteoarthritis in women: a twin study. BMJ 1996;112:940-9.
37. Hall L D, Watson P J, Tyler J A. Magnetic resonance imaging and the progression of osteoarthritis, osteoporosis, and aging. In: Hamerman D, ed. Osteoarthritis. Public health implications for an aging population. Baltimore: Johns Hopkins University Press, 1997: 215-29.
38. Johnston C C, Jr. Development of clinical practice guidelines for prevention and treatment of osteoporosis. Calcif Tissue Int 1996;59 (suppl 1):S30-3.
39. Cucvas P, Burgos J, Baird A. Basic libroblast growth factor (FGF) promotes cartilage repair in vivo. Biochem Biophys Res Commun 1988;156:611-8.
40. Brittberg M, Nilsson A, Lindahl A, Ohlsson C, Peterson L. Rabbit articular cartilage defects treated with autologous cultured chondrocytes. Clin Orthop 1996;326:270-81.
41. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1904;311:889-95.
42. Hunziker E B, Rosenberg L C. Repair of partial-thickness defects in articular cartilage: cell recruitment from the synovial membrane. J Bone Joint Surg 1996;78A:721-33.
43. Bruder S P, Jaiswal N, Haynesworth S H. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following eryopreservation. J Cell Biochem 1997;64:278-94.
44. Reddi A H. Cartilage morphogenesis: role of hone and cartilage morphogenetic proteins, homeobox genes and extracellular matrix. Matrix Biol 1994;14:599-606.
45. Luyten F P. Cartilage-derived morphogenetic proteins Key regulators in chondrocyte differentiation? Acta Orthop Scand 1995;66 (suppl 266):51-4.
46. Dequeker J, Boonen S, Aerssens J, Westhoven R. Inverse relationship osteoarthritis-osteoporosis: What is the evidence? What are the consequences? Br J Rheumatol 1996;35:813-20.
47. Hamerman D, Stanley E R. Implications of increased bone-density in osteoarthritis. J Bone Miner Res 1996; 11:1205-8.
48. Radin E L, Burr D B, Caterson B, Fyhrie D, Brown T D, Boyd R D. Mechanical determinants of osteoarthrosis. Semin Arthritis Rheum 1991;21 (suppl 2):12-21.
49. Li B, Aspden R M. Mechanical and material property's of the subchondral bone plate from the femoral head of patients with osteoarthritis or osteoporosis. Ann Rheum Dis 1997;56:247-54.
50. Carlson C S, Looser R F, Purser C B, Gardin J F, Jerome C P. Osteoarthritis in cynomolgus macaques III. Effects of age, gender, and subchondral bone thickness on the severity of the disease. J Bone Miner Res 1996;11:1209-17.
51. Smith M D, Triantafillou S, Parker A, Yousset P P, Coleman M. Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. J Rheumatol 1997;24:365-71.
52. Fenner H. The pharmaceutical industry and therapeutic approaches to osteoarthritis in the next decade. In: Hamerman D, ed. Osteoarthritis. Public health implication for an aging population. Baltimore: Johns Hopkins university Press, 1997:230-44.
53. Vincenti P M, Clark I M, Brickerholf C. H. Using inhibitors of metalloproteinases to treat arthritis. Easier said than done? Arthritis Rheum 1994;37:1115-26.
54. Brandt K D. Putting some muscle in osteoarthritis. Ann Intern Med 1997;128:154-6.
55. Orlander P R, Nader S. Youthful hormones. Lancet 1996;348 (suppl II):6.
56. Papadakis M A, Grady D, Black D, Tierney M J, Gooding G A W, Schambelan M, et al. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med 1996;124:708-16.
57. Ghiron L J, Thompson J L, Holloway L, Hintz R L, Butterfield G E, Hoffman A R, et al. Effects of recombinant insulin-like growth factor-1 and growth hormones on bone turnover in elderly women. J Bone Miner Res 1995; 10:1844-52.
58. Kirkwood T R L, Wolf S P. The biological basis of ageing. Age Ageing 1995;24:167-71.
59. Gilchrest B A, Bohr V A. Aging processes, DNA damage, and repair. FASEB J 1997;11: 322-30.
60. Morrison S J, Shah N M, Anderson D J. Regulatory mechanisms in stem cell biology. Cell 1 1997;88:287-98.
61. Taipale J, Keski-Oja J. Growth factors in the extracellular matrix. FASEB J 1997;11:51-9.
62. Rodan G A, Harada S. The missing bone. Gell 1997; 89:677-80.
63. Stein G S, Lian J B, Stein J L, Van Wijnen A J, Montecino M. Transcriptional control of osteoblast growth and differentiation. Physiol Rev 1996;76:593-629.
64. Vortkamp A, Lee K, Lanske B, Segre G V, Kronenberg H M, Tabin C J. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 1996; 273:613-22.
65. Campisi J, Dimri G, Hara E. Control of replicative senescence. In: Schneider E, Rowe J, eds. Handbook of the biology of aging. 4th ed. New York: Academic Press, 1996: 121-49.
66. Wang E. Senescent human fibroblasts resist programmed cell death, and failure to suppress bel 2 is involved. Cancer Res 1995;55:2284-92.
67. Hensler P, Pereira-Smith O M. Human replicative senescence. A molecular study. Am J Pathol 1995;147:1-8.
68. Noda A, Ning Y, Venable S F, Pereria-Smith O M, Smith J R. Cloning of senescent cell derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994;211:90-8.
69. Hara E, Smith R, Parry D, Tahara H, Peters G. Regulation of p!6 (CdkN2) expression and its implications for cell immortalization and senescence. Mol Cell Bid 1996; 16:859-67.
70. Weinberg R A. The cat and mouse games that genes, viruses, and cells play. Cell 1997;88:573-5.
71. Erlebacher A, Filvaroff E H, Gitelman S E, Derynck R. Toward a molecular understanding of skeletal development. Cell 1995;80:371-8.
72. Mundlos S, Olsen B R. Heritable diseases of the skeleton. Part II: Molecular insights into skeletal development -matrix components and their homeostasis. FASEB J 1997; 11:227-33.
73. Williams C J, Jimenez S A. Heredity, genes, and osteoarthritis. Rheum Dis Clin North Am 1993;19:523-43.
74. Popoff S N, Marks S C, Jr. The heterogeneity of the osteopetroses reflects the diversity of cellular influences during skeletal development. Bone 1995;17:437-45.
75. Pollard J W, Stanley E R. Pleiotropic roles for CSF-1 in development defined by the mouse mutation osteopetrotic (op). Adv Dev Biocheni 1996;4:1-53-93.
76. Cecchini M G, Dominguez M G, Mocci S, Wetterwald A, Felix R, Fleisch H, et al. Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development 1994;120:1357-72.
77. Soriano P, Montgomery C, Geske R, Radley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991;64:693-702.
78. Johnson R S, Spiegelman B M, Papaioannou V. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 1992;71:577-86.
79. Hughes M J, Lingrel J B, Krakowsky J M, Anderson K P. A helix-loop-helix transcription factor-like gene is located at the mi locus. J Biol Chem 1993;268:20687-90.
80. Simonet W S, Lacey D L, Dunstan C R, Kelley M, Chang M S, Lüthy R, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997, 89:309-19.
81. Tondravi M M, McKercher S R, Anderson K, Erdmann J M, Quiroz M, Makl R, et al. Osteopetrosis in mice lacking haematopoietic transcription factor PLM. Nature 1997; 386:81-4.
82. Rüther V, Garber C, Komitowski D, Müller R, Viagner E F. Deregulated c-fos expression interferes with normal bone development in transgenic mice. Nature 1987;325:412 6.
83. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, et al. Increased bone formation in osteocalcin-dericient mice. Nature 1996;382:448-52.
84. Luo G, Ducy P, McKee M D, Pinero G J, Loyer E, Behringer R B, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997;386:78-81.
85. Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, et al. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 1994;13:1189-96.
86. f integrin inhibits bone ŕsorption in vitro and prevents osteoporosis in vivo. J Clin Invest 1997;99:2284-92.
87. Korach K S, Couse J F, Curtis S W, Motley ST, Teitelbaum SL, Jepsen KJ, et al. Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Prog Horm Res 1996;51:159-85.
88. Smith E P, Boyd J, Frank G R, Takahashi H, Cohen R M, Specter B, et al. Estrogen resistance caused by a mutation in the estrogen receptor gene in a man. N Engl J Med 1995;331: 1056-61.
89. Lewis D B, Liggitt H D, Effman E L, Washburn TF, Lindzey J, Kimbro KS, et al. Osteoporosis induced in mice by overproduction of interleukin 4. Proc Natl Acad Sci 1996;90:11618-22.
90. Burton-Wurster N, Todhumer R J, Lust G. Animal models of osteoarthritis. In: Woessner J F, Jr, Howell D S, eds. Joint earning? degradation. Basic and clinical aspects. New York: Marcel Dekker, 1993: 347-84.
91. Weller A H, Magliato S A, Bell K P, Rosenberg N L. Spontaneous myopathy in the SJL/J mouse: pathology and strength loss. Muscle Nerve 1997;20:72-82.
92. Rawls A, Olson E N. MyoD meets its maker. Cell 1997;89:5-8.
93. Young M F. Transcription and aging of human bone tissue. Calcif Tissue Int 1995;56 (suppl 1):S39-40.
94. Angel P A, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991;1072:129-57.
95. Siddhanti S R, Quarles L D. Molecular to pharmacologic control of osteoblast proliferation and differentiation. J Cell Biochem 1994;55:310-20.
96. Hara E, Uzman J A, Dimri G P, Nehlin J O, Testori A, Campisi J. The helix-loop-helix protein Id-1 and a retinoblastoma protein binding mutant of SV40 T antigen synergize to reactivate DNA synthesis in senescent human fibroblasts. Dev Genet 1996;18:161-72.
97. Verbrugge L M. Recent, present, and future health of American adults. Annu Rev Public Health 1989;10:335-61.